May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
The Antioxidant Response Element as a Novel Biosensor for Diabetes
Author Affiliations & Notes
  • T. W. Prow
    Ophthalmology, Johns Hopkins Wilmer Eye Inst, Baltimore, Maryland
  • K. Uno
    Ophthalmology, Johns Hopkins Wilmer Eye Inst, Baltimore, Maryland
  • I. Bhutto
    Ophthalmology, Johns Hopkins Wilmer Eye Inst, Baltimore, Maryland
  • C. Merges
    Ophthalmology, Johns Hopkins Wilmer Eye Inst, Baltimore, Maryland
  • R. Grebe
    Ophthalmology, Johns Hopkins Wilmer Eye Inst, Baltimore, Maryland
  • G. Lutty
    Ophthalmology, Johns Hopkins Wilmer Eye Inst, Baltimore, Maryland
  • Footnotes
    Commercial Relationships T.W. Prow, None; K. Uno, None; I. Bhutto, None; C. Merges, None; R. Grebe, None; G. Lutty, None.
  • Footnotes
    Support This work was supported by NIH Grant EY01765 (Wilmer) and by a gift from the Himmelfarb Family Foundation in the name of Morton Goldberg, M.D.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 3640. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T. W. Prow, K. Uno, I. Bhutto, C. Merges, R. Grebe, G. Lutty; The Antioxidant Response Element as a Novel Biosensor for Diabetes. Invest. Ophthalmol. Vis. Sci. 2007;48(13):3640.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: This study was designed to test the hypothesis that the antioxidant response element (ARE) could be used to biologically detect oxidative stress in diabetes or hyperglycemia in living tissue and potentially be used as a conditional promoter for therapeutic gene expression to treat oxidative stress in diabetes. The first steps in this study were to characterize the activity of the ARE system in vitro during hyperglycemia and then evaluate levels of ARE-mediated expression in diabetic human eyes. Nrf2, the major transcription factor in this system, is known to localize to the nucleus to activate antioxidant gene expression during oxidative stress.

Methods:: Human retinal endothelial (HREC) and HL60 (a surrogate for circulating monocytes) cells were exposed to normoglycemic and hyperglycemic culture conditions (5, 10, and 30 mM glucose) for 3 days. Then, these cells were evaluated for nuclear translocation of the Nrf2 transcription factor through immunocytochemistry and Western blot analysis. HREC were also transfected with an ARE-driven EGFP reporter plasmid and evaluated for ARE activity through EGFP expression. Finally, adult human eye tissues from individuals with diabetes of varying severity were evaluated for nuclear localization of the Nrf2 transcription factor and HO-1 expression (an ARE driven antioxidant gene) by immunohistochemistry.

Results:: Both HREC and HL60 cells had increased Nrf2 nuclear localization with increased glucose concentration by Western blot analysis. However, the HL60 cells had a stronger response than the HREC. ARE mediated EGFP expression also increased with glucose concentration in HREC. The human immunohistochemical staining in diabetic human retina revealed a clear correlation between HO1 levels and the severity of diabetes. HO-1 expression increased significantly with severity of diabetes throughout inner retina including the retinal vasculature and perivascular cells. Nuclear localization of Nrf2 was also evident in many retinal cell types in severe diabetic patients.

Conclusions:: These data support the hypothesis that the ARE system could be used to drive synthetic antioxidant enzymes to treat oxidative stress in diabetes. Additionally, these data suggest that ARE functionality may play a role in diabetes progression.

Keywords: oxidation/oxidative or free radical damage • diabetic retinopathy • diabetes 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×